Galmed Pharmaceuticals Ltd.
GLMD
$1.56
$0.000.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.53M | 15.73M | 15.33M | 9.82M | 9.82M |
| Total Receivables | 433.00K | 447.00K | 209.00K | 135.00K | 135.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 463.00K | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 123.00K | 122.00K | 121.00K | 118.00K | 118.00K |
| Total Current Assets | 21.08M | 16.30M | 16.12M | 10.08M | 10.08M |
|
|
|||||
| Total Current Assets | 21.08M | 16.30M | 16.12M | 10.08M | 10.08M |
| Net Property, Plant & Equipment | -- | -- | 0.00 | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 267.00K | 267.00K | 257.00K | -- | -- |
| Total Assets | 22.94M | 18.68M | 18.50M | 13.34M | 13.34M |
|
|
|||||
| Total Accounts Payable | 1.37M | 1.31M | 1.31M | 1.20M | 1.20M |
| Total Accrued Expenses | -- | -- | 859.00K | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.05M | 499.00K | 6.00K | 351.00K | 351.00K |
| Total Other Current Liabilities | 1.05M | 499.00K | 6.00K | 351.00K | 351.00K |
| Total Current Liabilities | 2.42M | 1.81M | 2.17M | 1.55M | 1.55M |
|
|
|||||
| Total Current Liabilities | 2.42M | 1.81M | 2.17M | 1.55M | 1.55M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.42M | 1.81M | 2.17M | 1.55M | 1.55M |
|
|
|||||
| Common Stock & APIC | 224.99M | 218.85M | 217.21M | 207.57M | 207.57M |
| Retained Earnings | -204.07M | -201.57M | -200.47M | -195.35M | -195.35M |
| Treasury Stock & Other | -403.00K | -397.00K | -416.00K | -435.00K | -435.00K |
| Total Common Equity | 20.52M | 16.88M | 16.33M | 11.79M | 11.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.52M | 16.88M | 16.33M | 11.79M | 11.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.52M | 16.88M | 16.33M | 11.79M | 11.79M |
|
|
|||||